Related references
Note: Only part of the references are listed.Alemtuzumab vs. Interferon beta-1a in early multiple sclerosis
Alasdair J. Coles et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Quality assessment in multiple sclerosis therapy (QUASIMS) - A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis
Volker Limmroth et al.
JOURNAL OF NEUROLOGY (2007)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The window of therapeutic opportunity in multiple sclerosis
AJ Coles et al.
JOURNAL OF NEUROLOGY (2006)
Quantitative functional measures in MS: What is a reliable change?
SR Schwid et al.
NEUROLOGY (2002)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Share Paper
